Journal
PROTEOMICS CLINICAL APPLICATIONS
Volume 3, Issue 1, Pages 6-17Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.200800090
Keywords
Clinical proteomics; Diagnostics; Mass spectrometry; Profiling; Screening
Funding
- MRC [G0301107]
- Medical Research Council [G0301107] Funding Source: researchfish
Ask authors/readers for more resources
MS is an important analytical tool in clinical proteomics, primarily in the disease-specific discovery identification and characterisation of proteomic biomarkers and patterns. MS-based proteomics is increasingly used in clinical validation and diagnostic method development. The latter departs from the typical application of MS-based proteomics by exchanging some of the high performance of analysis for the throughput, robustness and simplicity required for clinical diagnostics. Although conventional MS-based proteomics has become an important field in clinical applications, some of the most recent MS technologies have not yet been extensively applied in clinical proteomics. in this review, we will describe the current state of MS in clinical proteomics and look to the future of this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available